Evidence map›Paper›PMID 37117002›Full record

ArticleBMJ open2023

Strategies used in managing conversations about prostate-specific antigen (PSA) testing among family physicians (FPs): a qualitative study.

S Michelle Driedger, Sarah Kirby, Ryan Maier, Roger Süss, Laurel Thorlacius, Jeffery W Saranchuk, Eric Bohm, Alexander Singer

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

S Michelle DriedgerDepartment of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-3769-5785
Sarah KirbyGeorge & Fay Yee Centre for Healthcare Innovation, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-5353-2559
Ryan MaierDepartment of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0003-4098-6751
Roger SüssDepartment of Family Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Laurel ThorlaciusDepartment of Pathology, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Jeffery W SaranchukDepartment of Surgery, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Eric BohmDepartment of Community Health Sciences, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Alexander SingerDepartment of Family Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada alexander.singer@umanitoba.ca.
University of Manitoba · CACancerCare Manitoba · CAGeorge & Fay Yee Centre for Healthcare Innovation · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesScreening for prostate cancer in healthy asymptomatic men using the prostate-specific antigen (PSA) test is controversial due to conflicting recommendations from and a lack of strong evidence regarding the benefit of population-based screening. In Canada and internationally, there is variability in how family physicians (FPs) approach PSA testing in asymptomatic men. The purpose of our study was to explore how family FPs approach discussions with their male patients around PSA testing in Manitoba, Canada.

designQualitative descriptive study. SETTING AND

participantsHigh-ordering and median-ordering FPs were invited to participate in an interview. In addition to exploring practice behaviours around PSA testing, participants were asked to elaborate on their typical discussion with asymptomatic men who request a PSA test or other tests and procedures that they do not feel are clinically warranted. Data were analysed inductively using a constant-comparison approach.

resultsThere were important variations between high-ordering and median-ordering FP's approaches to discussing PSA testing. Strategies to facilitate conversations were more frequently identified by median-ordering physicians and often included methods to facilitate assessing their patient's understanding and values. In addition to decision aids, median-ordering FPs used motivational interviewing to tailor a discussion, organised their practice structure and workflow habits in a way that enhanced patient-provider discussions and leveraged 'new' evidence and other aids to guide conversations with men.

conclusionWe found that high-ordering FPs tended to use the PSA test for screening asymptomatic men with limited shared decision-making. Median-ordering FPs used conversational strategies that emphasised uncertainty of benefit and potential risk and did not present the test as a recommendation.

Indexed as

Prostate-Specific AntigenProstatic NeoplasmsEarly Detection of CancerHumansMaleMass ScreeningPhysicians, FamilyProstate-Specific Antigenoncologyprimary health careprostate diseasequalitative research

Identifiers

PMID37117002
PMCPMC10151868
OpenAlexW4367309301

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.